MedTrace Logo

Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia

NCT04533919 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2026-04-06

No results posted yet for this study

Summary

This study investigates the pre-clinical nano-based analgesics in cells from human dorsal root ganglia (clusters of neurons). Collecting these neurons may help future research related to safe and effective pain treatment.

Conditions

  • Spinal Cord Neoplasm

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of dorsal root ganglia

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Andrew J Shepherd · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-16
Primary Completion
2026-01-30
Completion
2026-01-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04533919 on ClinicalTrials.gov